Updated staging system for lung cancer
- PMID: 21986263
- DOI: 10.1016/j.soc.2011.07.005
Updated staging system for lung cancer
Abstract
The seventh edition of TNM for Lung Cancer came into effect on the first of January 2011. Containing more than 100,000 cases of lung cancer treated by all modalities of care and from around the world, this is the largest database ever accumulated for this purpose. This edition allows detailed analysis and intensive validation such that the resultant classification aligns stage with prognosis more closely than ever before. There have been changes to certain tumor and metastasis descriptors and the resultant stage groupings. This article describes these changes, provides more in-depth discussion of the changes, and provides much additional information.
2011 Elsevier Inc. All rights reserved.
Similar articles
-
Updated lung cancer staging system.Future Oncol. 2009 Dec;5(10):1545-53. doi: 10.2217/fon.09.131. Future Oncol. 2009. PMID: 20001795
-
New TNM classification for non-small-cell lung cancer.Expert Rev Anticancer Ther. 2009 Apr;9(4):413-23. doi: 10.1586/era.09.11. Expert Rev Anticancer Ther. 2009. PMID: 19374596 Review.
-
Treatment implications of the new lung cancer staging system.Cleve Clin J Med. 2012 May;79 Electronic Suppl 1:eS7-eS10. doi: 10.3949/ccjm.79.s2.02. Cleve Clin J Med. 2012. PMID: 22614969
-
TNM-classification for lung cancer: from the 7th to the 8th edition.Acta Chir Belg. 2011 Nov-Dec;111(6):389-92. Acta Chir Belg. 2011. PMID: 22299327
-
New staging system: how does it affect our practice?J Clin Oncol. 2013 Mar 10;31(8):984-91. doi: 10.1200/JCO.2012.42.7922. Epub 2013 Feb 11. J Clin Oncol. 2013. PMID: 23401437 Review.
Cited by
-
Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.PLoS One. 2014 Nov 14;9(11):e112258. doi: 10.1371/journal.pone.0112258. eCollection 2014. PLoS One. 2014. PMID: 25396757 Free PMC article.
-
ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway.Int J Oncol. 2020 May;56(5):1175-1185. doi: 10.3892/ijo.2020.4994. Epub 2020 Feb 19. Int J Oncol. 2020. PMID: 32319569 Free PMC article.
-
Impact of Brachyury on epithelial-mesenchymal transitions and chemosensitivity in non-small cell lung cancer.Mol Med Rep. 2015 Jul;12(1):995-1001. doi: 10.3892/mmr.2015.3348. Epub 2015 Feb 13. Mol Med Rep. 2015. PMID: 25683840 Free PMC article.
-
Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer.Pathol Oncol Res. 2013 Apr;19(2):281-6. doi: 10.1007/s12253-012-9580-2. Epub 2012 Oct 20. Pathol Oncol Res. 2013. PMID: 23086683
-
Impact of p120-catenin isoforms 1A and 3A on epithelial mesenchymal transition of lung cancer cells expressing E-cadherin in different subcellular locations.PLoS One. 2014 Feb 4;9(2):e88064. doi: 10.1371/journal.pone.0088064. eCollection 2014. PLoS One. 2014. PMID: 24505377 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical